Board News and Announcements




JANUARY 2020 NEWSLETTER - Individuals wishing to subscribe to the quarterly NABP/NCBOP newsletter may do so here (follow link.)






MONDAY, MARCH 30, 2020

MUTUAL DRUG COMPLIING A LIST OF PHARMACISTS AND PHARMACY PERSONNEL TO ASSIST SHORT-STAFFED PHARMACIES DURING STATE OF EMERGENCY.  To mitigate any possible pharmacy staffing shortages during the COVID-19 outbreak, Mutual Drug is compiling a list of pharmacists, technicians, delivery drivers, and other pharmacy personnel who may be able to assist if a pharmacy becomes short-staffed. Please note that this resource will be made available to all pharmacies who may have a need. If you are willing to step in to assist a local pharmacy please complete the form below. Please contact Patrick Brown with any questions at or 919-598-4970.

NC Backup Pharmacy Staffing Survey



FRIDAY, MARCH 27, 2020

BOARD ANNOUNCES NEW PROCESS FOR OUT-OF-STATE PHARMACISTS AND OUT-OF-STATE CERTIFIED TECHNICIANS TO OBTAIN AUTHORIZATION TO PRACTICE IN NORTH CAROLINA DURING THE DECLARED STATE OF EMERGENCY.   When Governor Cooper declared a state-wide emergency on March 10, 2020 to coordinate response to the COVID-19, that triggered operation of the Board’s Emergency Services Waiver.  The Emergency Services Waiver allows a pharmacist or nationally-certified technician who has a license and registration in good standing in another state to practice in North Carolina during the declared emergency without being licensed or registered with the Board, provided the pharmacist and pharmacist-technician is pre-cleared to do so. 

Effective immediately, out-of-state pharmacists and out-of-state certified technicians who wish to practice in North Carolina during the declared state of emergency must obtain an NABP Passport to do so.  The NABP Passport is a license verification process administered by the National Association of Boards of Pharmacy to assist in the pandemic response.

Individuals can obtain an NABP Passport at no cost by following these steps (screenshot instructions are available here.)

  1.  Navigate to NABP’s e-Profile system at
  2. Click the  "Customers" tile.
  3. Enter your e-profile ID and Password.
  4. Click on the "My e-Profile" tile.
  5. Click on the tile labeled: “NABP Passport/COVID-19 Emergency”.   Note:  Your license information, including expiration date and license status must be current to access this tile.  If it is not current, please follow the instructions for updating.
  6. Follow the "Add a State” instructions on this page.  Check the attestation, and then click "Submit"
  7. NABP will verify your information and eligibility for a Passport.
  8. Once the NABP Passport for North Carolina is approved, you will be notified.  The North Carolina Board of Pharmacy will be notified as well, and you will then be eligible to practice in North Carolina during the state of emergency.



BOARD CERTIFIES RESULTS OF NORTHEASTERN DISTRICT ELECTION.  Please join the Board in congratulating Wallace Nelson of Hertford for being elected by North Carolina pharmacists to represent the Northeastern District.  The Board certified the Northeastern District election results by teleconference meeting on Thursday, March 26.  Please also join the Board in thanking Cornelius Toliver for a terrific campaign for the seat.  Click here to see the vote totals.




BOARD STAFF UPDATES GUIDANCE ON HAND SANITIZER PREPARATION.  Recognizing dwindling availability of USP-grade alcohol to prepare hand sanitizer, the United States Pharmacopeia has updated its guidance to pharmacies with best practices on substitution.  FDA has also issued guidance to industry on ethanol manufacturing for inclusion in hand sanitizer products (found here.)  Board staff updated its garb- and sanitizer shortage document to reflect the new USP and FDA guidance. The updated guidance is found here.




STATEWIDE SHELTER-IN-PLACE ORDER EFFECTIVE MONDAY, MARCH 30, 5 PM.  Governor Cooper has announced a state-wide shelter-in-place order that takes effect Monday, March 30, at 5 pm.  The Order permits pharmacies to remain open as essential businesses.  The Order does not require employees of an essential business to have documentation to report to work under the Order. See this FAQ on the Order.

Any pharmacist or pharmacy technician who nonetheless wishes to carry documentation may print additional copies of their annual license/renewal certificate, which may prove useful if some form of documentation is necessary to report to a pharmacy.  To do that:

    1.       Log in to your personal profile in the Board’s Licensure Gateway ( with your username and password.

    2.       If you've forgotten your username or password, please use the retrieval tools on the Licensure Gateway home page.

    3.       Once logged in, scroll down the bottom of your page, and click on the tile under Licenses/Certificates.

    4.       On the next page, click the PRINT ANNUAL CERTIFICATE button.  That will produce a savable, printable PDF file of your annual renewal certificate and license pocket card.


COVID-19 PANDEMIC UPDATES: TEMPORARY PHARMACY CLOSURES AND RELOCATIONSFollow this link for updates on North Carolina pharmacies temporarily closing or relocating their operations as part of COVID-19 emergency plans. Updated 3/31/20.






BOARD PASSES EMERGENCY RULES TO MITIGATE CERTAIN DRUG SHORTAGES.  On March 10, 2020, the Governor of North Carolina, by issuing Executive Order No. 116, declared a state of emergency to coordinate a response and enact protective measures to help prevent the spread of COVID-19.  COVID-19 is respiratory disease that can result in serious illness or death.  The search for potential treatments for COVID-19 has caused shortages and threatens to cause further shortages in certain drugs.  On March 24, 2020, the North Carolina Secretary of Health and Human Services and the State Health Director requested that the Medical Board and the Board of Pharmacy adopt the COVID-19 Drug Preservation Rule in order to alleviate shortages and ensure that these drugs are available to patients who need them. The Pharmacy Board’s emergency rule is found here.

An overview of the rule:

1              What drugs does the emergency rule apply to?  The rule creates a list of “restricted drugs”:  hydroxychloroquine, chloroquine, lopinavir-ritonavir, ribavirin, oseltamivir, darunavir, and azithromycyin.

2.            What restrictions does the rule apply to dispensing any of the Restricted Drugs?  A pharmacist shall fill or refill a prescription for a Restricted Drug only if that prescription bears a written diagnosis from the prescriber.  The diagnosis must be included in any electronic prescription as well.  A prescription for a Restricted Drug may be phoned in by a prescriber or a prescriber’s agent, but all of the information required by this rule must be recorded by the pharmacy, as well as the identity of the prescriber or prescriber’s agent transmitting the prescription.

3.            What if the diagnosis is COVID-19?  In that case, a pharmacist may dispense no more than a 14-day supply.  And that prescription may not be refilled.  Only a new prescription meeting the requirements of the rule may be filled.  No emergency refill may be provided for a Restricted Drug prescribed for a COVID-19 diagnosis.

4.            May a Restricted Drug be dispensed for prevention of, or in anticipation of, a COVID-19 infection?  No.  No prescription for a Restricted Drug may be dispensed to prevent on in anticipation of a COVID-19 infection.

5.            What if a patient was already taking a Restricted Drug for something other than COVID-19 prior to this rule?  The rule does not apply to prescriptions for a Restricted Drug for a patient previously established on that particular Restricted Drug on or before March 10, 2020.

6.            Does the emergency rule affect dispensing to in-patients at health-care facilities?  No.  Orders to administer a Restricted Drug to an inpatient of a health-are facility are not affected by this rule.

7.            Are prescribers governed by similar restrictions?  Yes.  The Medical Board has passed emergency rules that apply identical restrictions to prescribers:



A public hearing will be held on May 8, 2020 at 10AM by teleconference. Line number is 408-215-9377; access code is 829 609 515#

Comments from the public shall be directed to: Jay Campbell, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; fax 919-246-1056; email

Comment period begins March 24 and runs through May 1, 2020.

Emergency Rule-Making Findings of Need

Notice of Text / Proposed Temporary Rule




BOARD ISSUES ADDITIONAL GUIDANCE TO PHARMACIST-MANAGERS TAKING IN-PHARMACY MEASURES TO REDUCE THE RISK OF COVID-19 TRANSMISSION.  North Carolina law requires that a pharmacy, among other things, be "kept in a clean, orderly, and sanitary condition."  21 NCAC 46.1601.  "Sanitary" conditions plainly include conditions sufficient to minimize the risk of transmission of communicable disease within a pharmacy.

Under North Carolina law, the pharmacist-manager is the person to whom the Board issues a pharmacy permit (NCGS 90-85.21) and is, therefore, "the person who accepts responsibility for the operation of a pharmacy in conformance with all statutes and rules pertinent to the practice of pharmacy."  21 NCAC 46.1317(27).

The Board’s Expanded Emergency Services Waiver issued on March 17, 2020 stated, in part:
The Board strongly supports efforts by pharmacies and pharmacists to adjust work flows and processes within a pharmacy to reduce the risk of person-to-person coronavirus transmission.  Such efforts might include, but are not limited to:  not physically handling patient identifications at the point of dispensing; not requiring a physical signature for pick-up of a prescription; increasing use of prescription delivery service; limiting the number of patients physically entering a pharmacy; enforcing social distancing within a pharmacy. 

The Board emphasizes that the pharmacist-manager is the person authorized by law to ensure compliance with these standards.  Improper interference with a pharmacist-manager’s carrying out these duties and responsibilities subjects a pharmacy permit to potential disciplinary action, up to and including revocation.  Likewise, a person licensed by, or registered with, the Board who improperly interferes with a pharmacist-manager’s carrying out these duties and responsibilities is subject to potential disciplinary action, up to and including revocation. 



MONDAY, MARCH 23, 2020

PRESCRIPTIONS FOR HYDROXYCHLOROQUINE, CHLOROQUINE, AZITHROMYCIN, KALETRA, AND OTHER MEDICATIONS.   Board staff and public health officials at the North Carolina Department of Health and Human Services are aware of numerous reports from pharmacists across the state concerning new prescriptions for hydroxychloroquine, chloroquine, azithromycin, Kaletra, and potentially other medications – often in large quantities with a high number of refills -- to respond to the COVID-19 pandemic.  Reports include these prescriptions being issued by prescribers for themselves and family members, and for persons who have not been exposed to or infected by the COVID-19 virus.  Board staff and public health officials are aware that some prescription drug wholesalers are reporting shortages of these drugs.  Board staff are aware that at least three other state boards of pharmacies have passed emergency rules limiting the circumstances under which these drugs may be dispensed, and their quantities. 
All health care providers are reminded that, while these drugs are being investigated as potential COVID-19 treatments, there is at this date only anecdotal evidence of their potential usefulness.  Public health authorities are working to obtain better data on their potential  -- and most appropriate -- use in the pandemic.
Pharmacists are reminded of their ability to refuse to fill prescriptions that, in the pharmacist’s professional judgment, are not clinically appropriate.  And exercising that professional judgment may include setting reasonable policies designed to ensure that prescription drugs are available for all patients, including by use of partial fills of limited days’ supply and otherwise ensuring that patients taking these medications for established, and approved, indications do not have their drug therapy interrupted.  21 NCAC 46.1801.   
Public health officials at the North Carolina Department of Health and Human Services are working with appropriate stakeholders, including the Board of Pharmacy, to issue guidance and take actions on this issue that are designed to best protect the public health and safety.  Please continue to monitor the Board of Pharmacy website for updates on this, and other, issues. 



MONDAY, MARCH 23, 2020

FDA ISSUES GUIDANCE CONCERNING REMS REQUIREMENTS DURING THE COVID-19 PUBLIC HEALTH EMERGENCY.  The Food and Drug Administration (FDA) has issued guidance to health care professionals concerning REMS adherence during the COVID-19 public health emergency.  That guidance is found here In its most pertinent part, that guidance states:

For a limited number of drugs that are subject to a REMS with ETASU, the REMS requires laboratory testing ( e.g., liver enzyme testing) or imaging studies (e.g., magnetic resonance imaging) under sections 505-1(f)(3)(d) or (e) of the FD&C Act (21 U.S.C. 355-1 (f)(3)(d) or (e)).

FDA recognizes that during the COVID-19 PHE, completion of REMS-required laboratory testing or imaging studies may be difficult because patients may need to avoid public places and patients suspected of having COVID-19 may be self-isolating and/or subject to quarantine. Under these circumstances, undergoing laboratory testing or imaging studies in order to obtain a drug subject to a REMS can put patients and others at risk for transmission of the coronavirus.

For drugs subject to these REMS with laboratory testing or imaging requirements, health care providers prescribing and/or dispensing these drugs should consider whether there are compelling reasons not to complete these tests or studies during the PHE, and use their best medical judgment in weighing the benefits and risks of continuing treatment in the absence of laboratory testing and imaging studies.  Health care providers should also communicate with their patients regarding these judgments, including the risks associated with it. 

Although all REMS requirements remain in effect, FDA does not intend to take enforcement action against sponsors or others for accommodations made regarding laboratory testing or imaging study requirements imposed under sections 505-1(f)(3)(d) or (e) of the FD&C Act (21 U.S.C. 355-1 (f)(3)(d) or (e)) during the PHE declared by the Secretary of HHS on January 31, 2020, provided that such accommodations were made based on the judgment of a health care professional.  Manufacturers should document and summarize in their next REMS Assessment Report steps that were taken to accommodate patient access to these REMS drugs during this COVID-19 PHE.  



FRIDAY, MARCH 20, 2020

NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES CALLS FOR HEALTH CARE VOLUNTEERS.  DHHS Secretary Mandy Cohen issued this call for volunteers today (March 20, 2020):

As you know we are facing an unprecedented crisis from COVID-19 that has already had devastating consequences internationally. With the virus now spreading in North Carolina, we need to bolster our health care system to ensure we can care for those impacted by the virus. A crucial component is recruiting volunteers to supplement our health care workforce. I am writing today to ask you to register as a volunteer.

We are working through our State Medical Response System (SMRS), to recruit and manage volunteers in the following areas:

If you are able to volunteer, please register though the NC Training, Exercise, and Response Management System (NC TERMS). That system can be accessed through: We are also asking volunteers to provide medical supplies if they are able, including personal protective equipment.

A letter from NCDHHS Secretary Mandy Cohen with additional information is found here.

A guide for the NC TERMS system is found here.

The response to COVID-19 will require action at every level of government. As a health care professional you are critical to helping us make sure our health care system is prepared and ready to respond to this unprecedented challenge.

Thank you for your commitment to protecting the health and wellbeing of all North Carolinians.



FRIDAY, MARCH 20, 2020

UPDATE ON TEMPORARY REACTIVATION OF LICENSE TO PRACTICE PHARMACY.  Exercising its authority under NCGS 90-95.15(a) to waive provisions of the Pharmacy Practice Act and regulations during a declared emergency, the Board has created a pathway for the temporary reactivation of certain pharmacist licenses to provide patient care during the state of emergency. 

Only for the duration of the state of emergency declared by Executive Order No. 116, a pharmacist meeting the following criteria my apply for temporary reactivation of an expired North Carolina license to practice pharmacy:

A.            The license to practice pharmacy has been inactive for two years or less.

B.            The license did not become inactive as a result of a Board disciplinary order, voluntary surrender, or agreement not to renew.

C.            The pharmacist has not committed any act since the license became inactive that would be a basis for denying a license application under North Carolina General Statutes Section 90-85.38.

D.            The pharmacist has been invited or engaged to provide services at a North Carolina licensed pharmacy to assist with COVID-19 containment and treatment efforts.

E.            The pharmacist completes a temporary reactivation application (found here) and submits it to the Board at

F.            The pharmacist receives notification from the Board that the temporary reactivation application has been approved.

The Application for Temporary Reactivation of Pharmacist License is a fillable PDF document.  Once you have completed the application:  (1) Select “PRINT” from your Print Menu; (2) Select “SAVE AS PDF” option; (3) Email the completed application form to



FRIDAY, MARCH 20, 2020

DRUG ENFORCEMENT ADMINISTRATION (DEA) POSTS COVID-19 RESPONSE GUIDANCE TO HEALTH CARE PRACTITIONERS.  DEA has issued the following statement and guidance information to practitioners: 

The mission of Drug Enforcement Administrations (DEA), Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.

During this National Emergency the Diversion Control Division will continue to work with our Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.

On March 16, 2020, the DEA published a COVID-19 Information Page ( on the Diversion Control Divisions Web Site ( This page contains important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information. This site will be updated frequently as new information and guidance is issued. Please check back frequently for further information.

Please continue to direct all policy questions concerning COVID-19 to the Policy email box at




STATE EPIDEMIOLOGIST ASSESSES THAT COMMUNITY TRANSMISSION OF COVID-19 IS OCCURRING IN COMMUNITIES ACROSS NORTH CAROLINA:  RECOMMENDATIONS FOR PHARMACIES.  State Epidemiologist Zack Moore has issued a bulletin assessing that community transmission of COVID-19 is now occurring in communities across North Carolina.  Dr. Moore recommends that practices and healthcare facilities consider this latest assessment in implementing response plans to limit risks of person-to-person transmission. 

Reducing Risks of Person-to-Person Transmission.  Pharmacists and pharmacies are reminded that the Board’s March 17, 2020 expanded Emergency Services Waiver specifically authorizes the use of remote work technology by pharmacists and pharmacy personnel to mitigate this risk.  The March 17 expanded Emergency Services waiver also states more generally: 

*    *    *

The Board strongly supports efforts by pharmacies and pharmacists to adjust work flows and processes within a pharmacy to reduce the risk of person-to-person coronavirus transmission. Such efforts might include, but are not limited to: not physically handling patient identifications at the point of dispensing; not requiring a physical signature for pick-up of a prescription; increasing use of prescription delivery service; limiting the number of patients physically entering a pharmacy; enforcing social distancing within a pharmacy. The Board does not have authority to waive or modify terms of federal law, state law other than the Pharmacy Practice Act, or a pharmacy’s contracts. However, any entity–public or private –that purports to require that work flows include activities that unnecessarily increase the risk of person-to-person coronavirus transmission (e.g., requiring physical handling of a patient identification or requiring a physical signature) is advised in the strongest possible terms to prioritize public health and safety above other considerations.

*   *   *

Pharmacist-Administered Vaccines.  State public health officials recommend:

  1. Pharmacists continue to administer routine immunizations to non-symptomatic patients using ordinary precautions. 
  2. Pharmacists not administer immunizations to symptomatic patients.  Information on COVID-19 symptoms is found here:

Some immunizing pharmacists have inquired whether they may continue to administer vaccines if their provider-level CPR certification expires during the declared state of emergency.  In order to preserve the public safety, health, and welfare, the Executive Director has exercised authority delegated to him in the Board’s Emergency Services waiver to waive enforcement of the requirement than an immunizing pharmacist “hold a current provider level cardiopulmonary resuscitation certification issued by the American Heart Association or the American Red Cross, or an equivalent certification” (N.C.G.S. 90-85.3(i1)) for the duration of the declared state of emergency

The full text of the March 17, 2020 Expanded Emergency Services Waiver is found here:

The Board’s baseline Emergency Services Waiver is found here:

North Carolina DHHS is constantly updating information here:




BOARD OF PHARMACY EXPANDS EMERGENCY SERVICES WAIVER TO ADDRESS USE OF REMOTE OPERATIONS AND ALTERATIONS TO IN-PHARMACY WORKFLOWS.  Today (March 17, 2020), the Board of Pharmacy expanded its Emergency Services Waiver to authorize the use of certain remote operations as means of reducing the risk of person-to-person coronavirus transmission and to preserve pharmacists' ability to provide patient care.  The expanded waiver also provides support and encouragement for pharmacies seeking to adjust work flows and processes within a pharmacy to reduce the risk of person-to-person coronavirus transmission.

The expanded Emergency Services Waiver is found here.

The baseline Emergency Services Waiver is found here.



GOVERNOR COOPER DECLARES STATE OF EMERGENCY TO COORDINATE RESPONSE AND PROTECTIVE ACTIONS TO PREVENT THE SPREAD OF COVID-19.  On March 10, 2020, Governor Cooper declared a state-wide state of emergency to coordinate response to the COVID-19 (coronavirus) outbreak:

As a result of Governor's declaration and the specific recommendations for Triangle-area businesses and organizations from the North Carolina Department of Health and Human Services, the Board of Pharmacy's Tuesday, March 17, meeting will be held by teleconference.  The meeting will be largely informational.  The Board of Pharmacy office will not be open to the public on March 17.  *SEE BELOW FOR DIAL-IN INSTRUCTIONS.  All agenda items requiring a personal appearance before the Board will be rescheduled for a later meeting. 

The Governor's emergency declaration also triggers operation of the Board's Emergency Services Waiver order:  That waiver speaks specifically to pharmacists and nationally-certified technicians who are not licensed in North Carolina providing services in North Carolina during the declared emergency and to pharmacies that need to temporarily relocate as a result of the declared emergency.   All pharmacists are encouraged to review the waiver. 

Board staff will continue to update the pharmacy community as necessary.

CDC situation summary and FAQs may be found here:

Interim guidance for healthcare professionals:



SUNDAY, MARCH 15, 2020

Information for providers from Wake County Medical Director, Dr. Kim McDonald regarding recognizing and testing patients for COVID-19. Memo with important information for providers and links to other resources; and FAQs available here.




FDA ISSUES GUIDANCE TO INDUSTRY ON PREPARATION OF ALCOHOL-BASED HAND SANITIZER PRODUCTS DURING THE PUBLIC HEALTH EMERGENCY.  The federal Food and Drug Administration issued guidance to pharmacies today on the preparation of alcohol-based hand sanitizer products during the public health emergency.  Board staff have fielded a number of calls and emails from pharmacies prior to this guidance and have consistently advised that pharmacies should exercise professional judgment and follow best practices in preparing hand sanitizer products during the COVID-19 pandemic response.  Today’s guidance from the FDA establishes those best practices.



FRIDAY, MARCH 13, 2020

BOARD OF PHARMACY OFFICE CLOSED TO THE PUBLIC UNTIL FURTHER NOTICE.  Consistent with recommendations from public health authorities and Governor Cooper’s declared state of emergency responding to the COVID-19 pandemic, the Board of Pharmacy office is closed to the public until further notice.  Each of the Board’s application and other processes are available to our regulated community and the public through the Board’s website and by contacting Board staff, who remain available by phone and by e-mail.  Board staff will continue to provide updates on the Board’s website and through the Board’s Twitter account, .  

BOARD OF PHARMACY'S MARCH 17, 2020 MEETING WILL BE HELD BY TELECONFERENCE.  The Board of Pharmacy will hold its monthly business meeting by teleconference on Tuesday, March 17.  On Monday, March 16, Board staff will post a number that members of the public may use to access the meeting.  The Board’s agenda will be brief and largely informational.  Members of the public may not come to the Board office for the meeting.  Consistent with recommendations from public health authorities and Governor Cooper’s declared state of emergency, the Board office is closed to the public until further notice.

INFORMATION CONCERNING BOARD OF PHARMACY PERMIT MEETINGS.  Consistent with recommendations from public health authorities and Governor Cooper’s declared state of emergency responding to the COVID-19 pandemic, the Board of Pharmacy permit meeting scheduled for Monday, March 16, 2020 will not be held.  And future biweekly permit meetings are cancelled until further notice.
The Governor's emergency declaration, however, also triggered operation of the Board's Emergency Services Waiver order.  That order authorizes the Board's executive director to make case-by-case waivers of Pharmacy Practice Act requirements to preserve the public safety, health, and welfare during a state of emergency.   Accordingly, the Board's Executive Director has waived 21 NCAC 46.1606, which requires that the pharmacist-manager of an applicant pharmacy or the person in charge of a facility applying for a device and medical equipment permit to appear personally at the Board office prior to issuing a permit.

This waiver is limited to pharmacy or DME permit applicants that are notified by Board licensing staff of their eligibility to attend a permit meeting.  Permit applicants eligible to attend the March 16, 2020 permit meeting have already been notified.  Every two weeks, newly eligible permit applicants will be notified by e-mail.  If you have a question concerning the status of your permit application, please call or email Board licensing staff.  Do not travel to the Board office for the March 16 permit meeting or to inquire about application status.  The Board office is closed to the public until further notice.




UNITED STATES PHARMACOPEIA (USP) APPEALS PANEL ISSUES DECISIONS ON APPEALS CONCERNING REVISED CHAPTERS <795> AND <797>, AND NEW CHAPTER <825>  USP announced today (March 12, 2020) that its appeals panel issued final decisions concerning appeals to revisions of revised chapters <795> and <797>, and new chapter <825>.  More information concerning those decisions and their impact at the USP level is found here:

How do these decisions affect the Board’s current enforcement of USP chapter standards governing compounding?  At this point, they do not.  The Board’s December 12, 2019 statement continues to be current:

1.            Existing USP chapters <795> and <797> will continue to be enforced.  Board inspections and investigative staff will continue to use the inspection forms and tools mapped to existing USP chapter requirements (found here:  As pharmacists know, under both federal law (the Drug Quality and Security Act) and Board rule (21 NCAC 46.2801), compounding activities must conform with the standards in these chapters.   The revised chapters will be enforced when they go into effect.  USP did not set a new effective date in its announcement today.

2.            Board staff did not begin inspecting for compliance with USP chapter <800> standards in compounding activities on December 1, 2019, and will not being inspecting for such compliance as a result of today’s USP Appeals Panel decisions.  Chapter <800> was not subject to an appeal and went into effect on December 1, 2019.  Nonetheless, both the DQSA and Board rule .2801 require compliance with chapters <795> and <797> and other chapters incorporated into them.  Existing chapters <795> and <797> do not incorporate chapter <800>.  Revised chapters <795> and <797> do.  Accordingly, Board staff will begin inspecting for compliance with chapter <800> standards at such time as the revised chapters go into effect.  The USP Appeals Panel decisions remand revised chapters <795> and <797> to the Compounding Expert Committee for further study and engagement.  The Panel decisions do not set an effective date for revised chapters <795> and <797>.  Pharmacies that have already implemented changes to comply with chapter <800> are commended for doing so.  And pharmacies working toward chapter <800> compliance are strongly encouraged to take the time afforded by this delay to finalize those preparations.  For a review of prior Board statements concerning USP <800>, see and




NORTH CAROLINA DEPARTMENT OF INSURANCE ISSUES BULLETIN CONCERNING INSURER RESPONSIBILITIES FOR EMERGENCY REFILL PAYMENT DURING STATE OF EMERGENCY.  Pharmacists and pharmacies should review this memo from the North Carolina Department of Insurance reminding insurers of their responsibilities to cover emergency prescription refills during a declared state of emergency:

Pharmacists are reminded that Board Rules .1809 and .1815 provide authority to issue 30- and 90-day emergency refills, respectively, depending on the particular circumstances in your area. 




Voting began on March 11 in the North Carolina Board of Pharmacy's run-off election for the Northeastern District. NC pharmacists will cast their vote for either Wallace Nelson or Cornelius Toliver. Voting will be open through Wednesday, March 25, 2020.

Pharmacists, please log in to your profile through the Licensure Gateway and select the tile under your name that reads "RUN-OFF ELECTION NORTHEASTERN DISTRICT." There you may read about the two candidates before casting your vote.

All pharmacists residing in North Carolina and actively licensed by the Board as of October 31, 2019 are eligible to vote in this run-off election.

Please contact Board staff with questions.



Please join the Board in congratulating Dr. Ashley Duggins of Asheboro for being elected by North Carolina pharmacists to continue representing the Central District. The Board certified the Central District election results by conference call on Monday, March 2. Click here to see vote totals for this district.




ATTENTION ALL LICENSEES, REGISTRANTS, AND PERMIT HOLDERS - REGULAR RENEWAL PERIOD HAS ENDED. DME AND PHARMACY PERMIT HOLDERS MAY STILL RENEW WITH PENALTY. March 1, 2020 was the deadline to renew your pharmacist license, PA/NP or dispensing physician registration, or technician registration for the current year. Any license or registration that was not renewed has been moved to inactive status.

Pharmacy and DME permit holders who did not renew by the March 1 deadline may renew with a late penalty from March 2 through March 31. Any permit not renewed by March 31 will be closed. Log in and renew now via the Board’s Licensure Gateway: Click on the FACILITY MANAGEMENT tab to log in to your pharmacy or DME permit.




BOARD OF PHARMACY STATEMENT CONCERNING SUPERVISING PHYSICIAN INFORMATION ON PRESCRIPTIONS ISSUED BY PHYSICIAN ASSISTANTS AND NURSE PRACTITIONERS.  The North Carolina Medical Board's rules governing Physician Assistants (PAs) and Nurse Practitioners (NPs) state that prescriptions issued by these practitioners must contain the name of the practitioner's supervising physician (PAs and NPs) and the phone number of the supervising physician (PA only).  21 N.C.A.C. 32S.0212(5)(c); 21 NCAC 32M.0109(5)(A).  In recent months, a number of pharmacists have inquired whether a prescription from a PA or an NP lacking this information is "illegal," "invalid," or otherwise ineligible for dispensing by a pharmacist.
The answer is no.  The Medical Board's requirements are imposed on a PA or NP for purposes of the Medical Board's supervision of those practitioners.  The absence of a supervising physician’s name and telephone number does not render a PA- or NP-issued prescription "invalid," “illegal,” or otherwise ineligible for dispensing under the North Carolina Food Drug and Cosmetic Act or the North Carolina Pharmacy Practice Act.  These statutes set forth requirements for a valid prescription under North Carolina law – and neither requires supervising physician information to be included on PA- or NP-issued prescriptions. 
Accordingly, if the Medical Board wished to take action against a practitioner that it regulates for failure to include this information on a prescription, that is the Medical Board's prerogative.  But, again, that information's presence or absence does not affect a PA- or NP-issued prescription’s eligibility for dispensing by a pharmacist.  And if a pharmacist has concerns about a PA- or NP-issued prescription that the pharmacist cannot resolve after discussion with the prescriber, the Medical Board maintains an online database that readily identifies each and every PA's supervising physician(s): Likewise, the North Carolina Board of Nursing maintains an online database that readily identifies each and every NP’s supervising physician(s):








Read more about these proposed rule changes here.



NEW CE OPPORTUNITIES: PHARMACISTS & TECHNICIANS, Remember to check our CE page often for upcoming CE programs in your area. (LAST UPDATED MARCH 11, 2020.)



PHARMACY AND PHARMACIST-MANAGER RESPONSIBILITIES FOR PHARMACY INTERNS.  As pharmacists know, under North Carolina law, a student who is enrolled in a school of pharmacy is not required to register as a pharmacy technician.  See NCGS § 90-85.15A(e).  A student enrolled in a school of pharmacy is considered a “pharmacy intern” an is authorized to “perform all acts constituting the practice of pharmacy” while “working under a pharmacist preceptor or supervising pharmacist.”  21 NCAC 46.1317(29). 

In recent months, Board staff have become aware of two instances in which a person working in a pharmacy as a “pharmacy intern” was not (and never had been) a student enrolled in a school of pharmacy.  In both cases, investigations continue.

In the meantime, pharmacist-managers are reminded that, as the person who “accepts responsibility for the operation of a pharmacy in conformance with all statutes and rules pertinent to the practice of pharmacy” (21 NCAC 46.1317(27), your duties include vetting employees working as pharmacy interns to ensure that they are actually enrolled in a school of pharmacy.  The risk to the public of an unqualified person “performing all acts constituting the practice of pharmacy” is obvious.  A “pharmacy intern” who is not enrolled in a school of pharmacy is engaged in the unlicensed practice of pharmacy (which is a criminal offense) and the Pharmacy Practice Act specifically authorizes action on a pharmacist’s license or a pharmacy’s permit where either have “aided and abetted an individual to engage in the practice of pharmacy without a license.”  NCGS § 90-85.38(a)(9). 




Beginning February 8, 2018, the Board of Pharmacy opened an opioid public service announcement campaign on Wilmington and Greenville-area television stations and on social media platforms. The advertisements feature Joe Adams, a pharmacist and past president of the National Association of Boards of Pharmacy, sharing his deeply personal story of losing his son to an opioid overdose in 2014. These ads emphasize the important of obtaining help and the critical role pharmacists can play.

The ads come in 30-second, 60-second, and 6-minute versions, and are available for download here. Board members and staff welcome and encourage pharmacists using these ads to educate their patients and communities about proper medication use and the dangers of opioid abuse.

The Board thanks Third Wheel Media of Chapel Hill and the National Association of Boards of Pharmacy (NABP) for their tremendous efforts on this issue. Pharmacists will note that texting “abuse” to 555888, as instructed in the ads, will result in a reply text providing a link to an NABP-created and hosted page containing resources for pharmacists to share with patients and their communities. That page may be accessed directly here:

These ads are the first phase of a multi-media campaign. Board staff will continue to keep pharmacists updated as the campaign progresses.

Please contact Board staff at 919.246.1050 with questions.



The North Carolina Board of Pharmacy's monthly meetings are live-streamed via YouTube. Follow the link below to subscribe to the Board's YouTube channel. Meeting dates found here.



Health Advisories (last updated October 10, 2018) - Check here regularly for the latest alerts and recall notices.



Medicare/Medicaid (last updated January 3, 2018) - Check here regularly for the latest updates regarding Medicare/Medicaid.


Looking for a news item that is no longer here? Try our search page or send an email to Kristin Moore.


The North Carolina Board of Pharmacy's mission is to protect the public health, safety and welfare in pharmaceutical matters. The Board sets standards for academic and practical experience programs prior to licensure, issues permits to operate pharmacies and DME facilities, and annually renews licenses, permits and registrations.

For more information, please see About the NCBOP.

Copyright © 2006 North Carolina Board of Pharmacy
site design IV Design